NCT02962570

Brief Summary

The main goal of this study is to determine if supplemental oxygen given only when the patient is inspiring (demand delivery) is more effective than constant-flow oxygen given during all phases of the breath regardless if the patient is breathing it in. A previous study in volunteers (NCT02886312) showed that the oxygen saturation in the blood and the concentration of oxygen breathed out from the lungs (end-tidal oxygen) was higher when given in demand (inhalation only) mode. A secondary goal is to determine in patients, whether turning oxygen delivery off during expiration improves the accuracy of end-tidal CO2 (Carbon Dioxide) monitoring. This was found to be the case in the previous volunteer study. The investigators want to determine if these improvements are also observable in relatively healthy patients undergoing procedural sedation and analgesia. The efficacy of the demand mode will be determined by measuring the resulting difference in oxygen saturation and end-tidal oxygen levels. The investigators will alternate between traditional oxygen delivery (continuous flow) and demand delivery (flow only during inhalation) for two minutes in each mode after which oxygen saturation and end-tidal oxygen will be measured. End-tidal CO2 measurement will be compared with those during the brief time when O2 flow is stopped.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Nov 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Nov 2016Nov 2026

Study Start

First participant enrolled

November 1, 2016

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

10 years

First QC Date

November 7, 2016

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • End-tidal Oxygen

    Did the novel system increase end-tidal oxygen?

    measured every 140 seconds minutes throughout the surgical procedure

  • Oxygen Saturation

    Did the novel system increase oxygen saturation?

    measured continuously with every heart beat (i.e., approx. every 500-2000msec) throughout the surgical procedure

  • End-tidal Carbon Dioxide

    Was end-tidal carbon dioxide measured more accurately using the novel system?

    measured every 140 seconds minutes throughout the surgical procedure

Study Arms (1)

Only Arm

EXPERIMENTAL

Two minutes: Intervention: Device: On Demand Oxygen Delivery 20 sec or 3 breaths, whatever comes first: Intervention: Device: Oxygen Flow Stopped Two minutes intervention: Device: Traditional, Always-On, Oxygen Delivery 20 sec or 3 breaths, whatever comes first: Intervention: Device: Oxygen Flow Stopped Repeat until the end of the surgical procedure

Device: On Demand Oxygen DeliveryDevice: Traditional, Always-On, Oxygen DeliveryDevice: Oxygen Flow Stopped

Interventions

Supplemental oxygen flow is controlled such that it is on only during inhalation.

Only Arm

Supplemental oxygen flow is constantly on, irrespective of whether the patient is inhaling or exhaling.

Only Arm

Supplemental oxygen flow is stopped completely for a brief period to allow undisturbed end-tidal oxygen and CO2 measurements

Only Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA class I-III

You may not qualify if:

  • Procedures scheduled for a lime less than 20 minutes
  • Age \< 18 years
  • Baseline SpO2 (arterial oxygen saturation as measured by pulse oximetry) \< 93% on room air
  • ARDS (Acute respiratory distress syndrome), lung disease, cardiovascular disease
  • ASA class IV or above
  • Pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84112, United States

Location

Related Publications (3)

  • Bliss PL, McCoy RW, Adams AB. Characteristics of demand oxygen delivery systems: maximum output and setting recommendations. Respir Care. 2004 Feb;49(2):160-5.

    PMID: 14744265BACKGROUND
  • Fuhrman C, Chouaid C, Herigault R, Housset B, Adnot S. Comparison of four demand oxygen delivery systems at rest and during exercise for chronic obstructive pulmonary disease. Respir Med. 2004 Oct;98(10):938-44. doi: 10.1016/j.rmed.2004.03.010.

    PMID: 15481269BACKGROUND
  • Godbold S, Lowe G, Willis R. Healthcare Professionals Accuracy and Consistency in Setting Oxygen Flowmeters for Patients in an Intensive Care Unit. Respir. Care 59(10):OF26, December 2014.

    BACKGROUND

Study Officials

  • Kai Kuck, Ph.D.

    University of Utah Department of Anesthesiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D.

Study Record Dates

First Submitted

November 7, 2016

First Posted

November 11, 2016

Study Start

November 1, 2016

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data.

Locations